1. 1416PImmunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO). (23rd October 2018) Authors: Ferrara, R; Naigeon, M; Auclin, E; Duchemann, B; Cassard, L; Medhi, J; Boselli, L; Grivel, J; Desnoyer, A; Mezquita, L; Aboubakar, F; Hendriks, L; Planchard, D; Caramella, C; Remon, J; Ngocamus, M; Nicotra, C; Besse, B; Chaput, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1408PPrognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI). (23rd October 2018) Authors: Hendriks, L; Henon, C; Auclin, E; Mezquita, L; Ferrara, R; Audigier Valette, C; Mazieres, J; Lefebvre, C; Le Moulec, S; Duchemann, B; Le Pechoux, C; Botticella, A; Ammari, S; Gazzah, A; Caramella, C; Adam, J; Planchard, D; De Ruysscher, D; Dingemans, A-M C; Besse, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 17P Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients. (15th December 2019) Authors: Blanc-Durand, F; Auclin, E; Planchard, D; Aix, S Ponce; Hendriks, L; Sullivan, I G; Saravia, D; Routy, B; Castro, R Lopez; Pilotto, S; Aboubakar, F; Kassouf, E; Rodriguez, A; Martin, A Amores; Bluthgen, M V; Duchemann, B; Caramella, C; Nadal, E; Besse, B; Mezquita, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗